Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
for Bipolar I Disorder
26 locations incl. Bentonville
Sponsor: LB Pharmaceuticals Inc.
Sex: All·Age: 18 - 65
Code: NCT07494305·Phase 2·Recruiting·Listed Mar 2026